We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Ultrasound Examination and Guided Injection Into the Acromio-clavicular Joint

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01628796
Recruitment Status : Unknown
Verified June 2012 by gordon edelson, The Baruch Padeh Medical Center, Poriya.
Recruitment status was:  Not yet recruiting
First Posted : June 27, 2012
Last Update Posted : June 27, 2012
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
Is it possible to improve the accuracy of injection into the acromio-clavicular joint with the use of ultrasound?

Condition or disease Intervention/treatment
Osteoarthritis of Acromioclavicular Joint Other: contrast material injection

Study Design

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 30 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: Ultrasound Measurement of the Acromio-clavicular Joint and Injection of Standard Contrast Material Into the Joint Under Ultrasonic Control
Study Start Date : July 2012
Estimated Primary Completion Date : January 2013
Estimated Study Completion Date : January 2013

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arms and Interventions

Intervention Details:
    Other: contrast material injection
    using ultrasound to locate ac joint and injecting contrast material to ensure that the dye is actually in the joint
    Other Name: iomeron 350

Outcome Measures

Primary Outcome Measures :
  1. ultrasound controlled injection of contrast material into the AC joint followed by standard x-ray [ Time Frame: outcome assessed at the time of the injection (1 day) ]
    standard x-ray will be taken after the contrast dye has been injected into the joint to see whether it has successfully been placed into the joint.


Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • adults over 18 years with AC joint degenerative changes
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01628796


Contacts
Contact: Gordon Edelson, MD 97246652670 edelson@bezeqint.net

Sponsors and Collaborators
The Baruch Padeh Medical Center, Poriya
More Information

Responsible Party: gordon edelson, Professor of Orthopedic Surgery, The Baruch Padeh Medical Center, Poriya
ClinicalTrials.gov Identifier: NCT01628796     History of Changes
Other Study ID Numbers: 08-2012.CTIL
First Posted: June 27, 2012    Key Record Dates
Last Update Posted: June 27, 2012
Last Verified: June 2012

Additional relevant MeSH terms:
Osteoarthritis
Arthritis
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases